Vascular Regeneration CLI Protocol

Critical Limb Ischemia
Stem Cell Therapy
in Costa Rica

Advanced non-surgical stem cell therapy for critical limb ischemia (CLI), designed to improve blood flow, reduce pain, and support natural tissue repair. Our regenerative approach targets the root cause of poor circulation, helping patients heal, regain mobility, and lower the risk of amputation.

Book Your Appointment Today

Advanced Vascular Matrix

Targeted Circulatory Repair

Stem cell therapy currently provides promising results in restoring blood flow to ischemic limb tissue. They can support new vessel formation, easing pain and reducing the risk of amputation.

Global Clinical Scope

Treatment Of More Than 25 Diseases With Stem Cells.

Overview Critical Limb Ischemia (CLI)
Diagnosis Cause & Symptoms
Therapy Model Treatment Protocol
Clinical Profile

What is Critical Limb
Ischemia (CLI)?

Critical limb ischemia occurs when arteries become severely blocked, reducing blood flow to the legs and feet. Over time, this lack of circulation leads to tissue damage, chronic pain, and non-healing wounds.

Unlike early-stage peripheral vascular disease, CLI is a medical emergency that can quickly progress if left untreated.

Without Effective Treatment

CLI often leads to limb amputation, making early intervention with stem cell therapy for poor circulation critical.

Critical limb ischemia affecting circulation in the feet
Reduced Circulation
Non-healing ulcers Infection risk Poor circulation Persistent pain Skin discoloration
Treatment Pathways

Standard Care vs. Regenerative Therapy

Conventional Approach

Why Traditional Treatments Fall Short

Many patients come to us after trying conventional treatments that provide limited or temporary relief.

High risk of recurrence or complications
Procedures can be invasive with long recovery times
Medications only manage symptoms, not the root cause
Poor outcomes in advanced peripheral artery disease cases
Surgical bypass or angioplasty may not be suitable for all patients
Regenerative Approach

How Stem Cell Therapy for CLI Works

Stem cell therapy for CLI targets the underlying cause of poor circulation — damaged or blocked blood vessels — repairing and restoring function at a cellular level.

01 Stem cells are introduced into affected areas
02 They stimulate angiogenesis (new blood vessel formation)
03 Blood flow improves in oxygen-deprived tissues
04 Damaged cells begin to repair and regenerate
Supports natural tissue regeneration and healing
Patient Outcomes

Key Benefits of Stem Cell Therapy in Costa Rica

Patients who choose stem cell therapy in Costa Rica for critical limb ischemia experience both clinical and lifestyle improvements.

Lower Risk of Amputation

Targets circulation loss at its source to help preserve limb viability.

Reduced Pain & Inflammation

Calms inflammatory response in affected tissue for lasting relief.

Faster Healing of Wounds

Accelerates closure of chronic ulcers and non-healing sores.

Improved Blood Flow

Supports new vessel formation to legs and feet (angiogenesis).

Increased Mobility

Restores independence and day-to-day quality of life.

Minimally Invasive

Non-surgical procedure with a significantly faster recovery.

Many patients are now choosing critical limb ischemia stem cell treatment as a safer, non-surgical option to manage poor circulation and reduce the risk of complications.

Destination

Why Choose Costa Rica for Stem Cell Therapy?

Costa Rica has become a leading destination for medical tourism, attracting stem cell therapy patients from the U.S., Canada, and worldwide.

What Makes It a Top Choice

  • Personalized care with shorter wait times

  • Advanced medical facilities and technology

  • Peaceful environment ideal for healing and recovery

  • Experienced specialists in regenerative vascular therapy

  • Affordable, high-quality stem cell treatment for circulation disorders

Patients gain access to advanced care while avoiding the high treatment costs common in their home countries.

Eligibility

Who is a Good Candidate for Stem Cell Therapy?

You may be a candidate for stem cell therapy for critical limb ischemia if you:

Want to avoid amputation
Are not a suitable candidate for surgery
Have been diagnosed with CLI or advanced PAD
Experience chronic pain or non-healing wounds
Have not seen improvement with traditional treatments
Each patient undergoes a detailed evaluation for a personalized regenerative plan
Care Philosophy

Our Personalized Treatment Approach

We believe successful outcomes depend on tailored care, not one-size-fits-all solutions.

Our Process Includes
01 Comprehensive medical assessment
02 Continuous monitoring and follow-up
03 Customized stem cell therapy protocol for CLI
04 Support for recovery and lifestyle adjustments

This ensures that every patient receives targeted care focused on long-term healing and improved circulation.

Patient Results

Real Outcomes: What Patients Experience

Patients undergoing stem cell therapy for CLI often report:

Healing of chronic wounds
Reduced dependency on pain medications
Noticeable improvement in circulation within weeks
Increased ability to walk and perform daily activities
These outcomes highlight the effectiveness of regenerative medicine for peripheral artery disease

All about Stem Cells Bio Clinic

Don’t wait until symptoms worsen. Early treatment with non-surgical stem cell therapy for critical limb ischemia can help restore circulation, heal damaged tissue, and reduce the risk of amputation. Book your consultation today and take the first step toward recovery.

Book Your Appointment Today

Scientific References:

01

Qadura, M., Terenzi, D. C., Verma, S., Al-Omran, M., & Hess, D. A. (2018). Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies. Stem Cells, 36(2), 161–171. https://doi.org/10.1002/stem.2751

02

Xie, B., Luo, H., Zhang, Y., Wang, Q., Zhou, C., & Xu, D. (2018). Autologous Stem Cell Therapy in Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Trials. Stem Cells International, vol. 2018, Article ID 7528464, 12 pages. https://doi.org/10.1155/2018/7528464

03

Sun, R. (2016). Advances in stem cell therapy for cardiovascular disease (Review). National Journal of Molecular Medicine, 38, 23–29.

04

Teraa, M., et al. (2016). Critical Limb Ischemia: Current Trends and Future Directions. Journal of the American Heart Association, 5, e002938. https://doi.org/10.1161/JAHA.115.002938

05

Yan, J., Tie, G., Xu, T. Y., Cecchini, K., & Messina, L. M. (2013). Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy. Stem Cell Reviews and Reports, 9(3), 360–372.

06

Compagna, R., et al. (2015). Cell Therapy in Patients with Critical Limb Ischemia. Stem Cells International, vol. 2015, Article ID 931420, 13 pages.